Navigation Links
A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss
Date:12/17/2008

species making up the cetacean order has its own acoustic repertoire directly related to the habitat where it has evolved over the course of millions of years. In order to detect their prey, coastal species must be able to accurately trace the outline and details of short-range features, while the absence of such features in the high seas means the cetaceans that inhabit them (pelagic species) have more need of medium- and long-range data on the presence of fish schools. However, all odontocetes or toothed cetaceans share the same method of sound production, which includes the passage of air though their nasal conducts and its expulsion by specialized tissues known as phonic lips located in the upper part of the head. While the mammal is immersed, this air is recycled and allows them to vocalize for the purpose of social communication or echolocation, depending on the need at hand.

The absence of vocal chords is accompanied by another trait unique among the mammals: that of not using an external auditory conduct for the purposes of hearing. Instead, they pick up sound waves through their jaws which transmit the information directly to the middle or inner ear where it is processed then relayed to the brain.

The work of the BBVA Foundation project team will help develop bioindicators of the damage caused by human-produced noise in the marine environment, as a first step to combating this pollution source and establishing a balance between the conduct of human activities and the conservation of marine mammals.


'/>"/>

Contact: Javier Fernandez
comunicacion@fbbva.es
34-913-746-615
Fundacin BBVA
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Balzan Foundation announces 2007 winners
2. Keck Foundation funds study of biological interactions with nanomaterials
3. Yu receives research funding from the Wallace H. Coulter Foundation
4. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
5. Simons Foundation awards Emory scientists $3M for autism gene research
6. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
7. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
10. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
11. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... The loss of a gene through deletion of genetic m...icant abnormalities in learning and behavior, said... of Medicine ( www.bcm.edu ) in a report that appe... , "This research goes about 95 percent of the w...f individuals to this gene," said Dr. Arthur L. Be...
(Date:11/6/2009)...wire/ -- Auburn Hills, MI-based Law Enforcement In...ts locker system and patent-pending Biometric Acce...t of Health and Human Services, National Institute...er system will support the NIH,s entire police for... medical research agency. The project is expected...
(Date:11/4/2009)...ntists are reluctant to officially endorse green t...es to grow about its protective effects, including...ntion Research , a journal of the American Associa...ction in oral cancer. , Vassiliki Papadimitrako...nt of Thoracic/Head and Neck Medical Oncology at t...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 1New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 3New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 1Full Transcript of Pelosi Press Conference on Health Care Reform 51561 2Full Transcript of Pelosi Press Conference on Health Care Reform 51561 3Full Transcript of Pelosi Press Conference on Health Care Reform 51561 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 5Full Transcript of Pelosi Press Conference on Health Care Reform 51561 6Full Transcript of Pelosi Press Conference on Health Care Reform 51561 7Full Transcript of Pelosi Press Conference on Health Care Reform 51561 8Full Transcript of Pelosi Press Conference on Health Care Reform 51561 9Full Transcript of Pelosi Press Conference on Health Care Reform 51561 10Full Transcript of Pelosi Press Conference on Health Care Reform 51561 11Full Transcript of Pelosi Press Conference on Health Care Reform 51561 12Full Transcript of Pelosi Press Conference on Health Care Reform 51561 13Full Transcript of Pelosi Press Conference on Health Care Reform 51561 14Full Transcript of Pelosi Press Conference on Health Care Reform 51561 15Full Transcript of Pelosi Press Conference on Health Care Reform 51561 16Full Transcript of Pelosi Press Conference on Health Care Reform 51561 17Full Transcript of Pelosi Press Conference on Health Care Reform 51561 18TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 1TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 2
...are being slaughtered for their ivory at a pace un... took effect in 1989. But the public outcry that r...ity of Washington conservation biologist contends ...e giant mammals, plight. , The elephant death ra...ent a year based on recent studies, which is actua...
...d - Kiwifruit lovers can look forward to new, nove...ease this week of crucial genetic data which fruit...arieties with increased health properties and exci...ealand-based fruit science company HortResearch an...rch and Development Corporation Limited announced ...
...d a drug to achieve normal levels of blood sugar i...y high insulin levels. If this approach succeeds i...or children with congenital hyperinsulinism, a rar...hich insulin levels become dangerously high. , "T...or children with the most common type of congenita...
Other Biology News:Ivory poaching at critical levels: Elephants on path to extinction by 2020? 2Ivory poaching at critical levels: Elephants on path to extinction by 2020? 3Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3Treatment corrects severe insulin imbalance in animal studies 2Treatment corrects severe insulin imbalance in animal studies 3
(Date:11/6/2009)...D, Calif., Nov. 6 Intarcia Therape...ts ITCA 650 (DUROS® continuous delivery of ex...tes at the Ninth Annual Diabetes Technology Meetin...ewscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,... Via ITCA 650 Lowers Plasma Glucose, HbA1c and Red...
(Date:11/5/2009)...RSBURG, Md., Nov. 5 GenV...ncial results for the third quarter ended Septembe...lion ($0.04 per share) for the three months ended ...million ($0.08 per share) in the comparable quarte... 2009, GenVec,s net loss was $14.1 million ($0.15 ...
(Date:11/5/2009)...EGO, Nov. 5 Imagenetix, ...hat William Spencer, President and CEO of Imagenet...2nd annual LD MICRO Conference on Thursday, Decemb...Angeles. ,, About LD MICRO ,, LD MICRO is a ... finding undervalued companies in the micro-cap sp...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ALTHAM, Mass., Aug. 18 Logical Therapeutics, Inc....nt of medicines that treat,diseases associated wit...the successful completion of its Phase 1b randomiz...cs study of LT-NS001, the Company,s proprietary,na...m December, 2007,through July, 2008 in normal adul...
...AN DIEGO, Aug. 18 LifeVantage Corporation,(OTC Bu...e only product,clinically proven to slow the progr...pany,s President & CEO, David Brown, is featured i...Press Show., The interview gives viewers an overv...mpany,s latest press release., To view the cli...
...HILADELPHIA, Aug. 17 /Xinhua-PRNewswire/ -- WuXi A...ech (NYSE: WX ) in the U.S., has announced,the ap... of Operations and,Joseph Hughes, Ph.D. as Vice Pr...acility., (Logo: http://www.newscom.com/cgi-bin/...ith the company for nine years in roles of,increas...
Other Biology Technology:Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 2[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2
Smarter Fermentation System Controller for One Vessel from Major Science
...are specifically depleted of a single complement p..., the alternative and classical pathways are left ... detection and quantitation of hemolytically activ...used to assess complement activation in non-human ...
Dispensing Bins from Terra Universal, Inc.
Midgard Prec Current Source from Stoelting Co.
Biology Products: